Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
0.7040
-0.0040 (-0.56%)
Jun 5, 2025, 2:58 PM - Market open

Dermata Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Cash & Equivalents
9.723.167.446.2410.80.53
Upgrade
Cash & Short-Term Investments
9.723.167.446.2410.80.53
Upgrade
Cash Growth
105.32%-57.49%19.18%-42.20%1935.97%-73.37%
Upgrade
Other Receivables
---0.01--
Upgrade
Receivables
---0.01--
Upgrade
Prepaid Expenses
0.290.360.450.60.770.08
Upgrade
Other Current Assets
-0.010.090.090.06-
Upgrade
Total Current Assets
10.013.537.986.9411.620.61
Upgrade
Total Assets
10.013.537.986.9411.620.61
Upgrade
Accounts Payable
1.40.810.870.50.520.1
Upgrade
Accrued Expenses
1.311.160.760.4310.13
Upgrade
Short-Term Debt
-----2.99
Upgrade
Current Portion of Long-Term Debt
-----0.56
Upgrade
Total Current Liabilities
2.71.971.620.921.523.78
Upgrade
Total Liabilities
2.71.971.620.921.523.78
Upgrade
Common Stock
000002.35
Upgrade
Additional Paid-In Capital
75.2867.2459.7451.6146.09-
Upgrade
Retained Earnings
-67.98-65.68-53.39-45.59-35.98-28.08
Upgrade
Total Common Equity
7.31.566.366.0210.11-25.73
Upgrade
Shareholders' Equity
7.31.566.366.0210.11-3.18
Upgrade
Total Liabilities & Equity
10.013.537.986.9411.620.61
Upgrade
Total Debt
-----3.55
Upgrade
Net Cash (Debt)
9.723.167.446.2410.8-3.02
Upgrade
Net Cash Growth
105.32%-57.49%19.18%-42.20%--
Upgrade
Net Cash Per Share
3.592.0738.16135.55602.41-
Upgrade
Filing Date Shares Outstanding
6.035.430.440.050.0346.66
Upgrade
Total Common Shares Outstanding
6.032.520.260.050.0346.66
Upgrade
Working Capital
7.31.566.366.0210.11-3.18
Upgrade
Book Value Per Share
1.210.6224.25117.29291.25-0.55
Upgrade
Tangible Book Value
7.31.566.366.0210.11-25.73
Upgrade
Tangible Book Value Per Share
1.210.6224.25117.29291.25-0.55
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q